Celldex Therapeutics, Inc. (CLDX) vs Harmony Biosciences Holdings, Inc. (HRMY)
Celldex Therapeutics, Inc. and Harmony Biosciences Holdings, Inc. are both Biotechnology companies. Celldex Therapeutics, Inc. and Harmony Biosciences Holdings, Inc. are of similar size ($2.5B and $2.4B). Celldex Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 13.2×. Harmony Biosciences Holdings, Inc. grew revenue faster over the last twelve months: 24.3% against −88.3%. Harmony Biosciences Holdings, Inc. has the higher net margin (18.9% vs −33,883.8%) and the higher return on invested capital (29.7% vs 0.00%). Across the 18 metrics below, Harmony Biosciences Holdings, Inc. leads on 15 and Celldex Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | CLDX | HRMY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 75.42% | 65.16% |
| Operating margin | (36,733.82%) | 24.03% | 0.00% |
| Net margin | (33,883.77%) | 18.88% | 0.00% |
| Free cash flow margin | (27,294.81%) | 36.99% | 0.00% |
| Return on equity | (43.88%) | 20.46% | (57.72%) |
| Return on assets | (40.76%) | 14.61% | (49.22%) |
| Return on invested capital | 0.00% | 29.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack